Ontology highlight
ABSTRACT:
SUBMITTER: Kyriakou E
PROVIDER: S-EPMC6714834 | biostudies-other | 2018 Oct
REPOSITORIES: biostudies-other
Kyriakou Elias E Katogiannis Konstantinos K Ikonomidis Ignatios I Giallouros George G Nikolopoulos Georgios K GK Rapti Evdoxia E Taichert Maria M Pantavou Katerina K Gialeraki Argiri A Kousathana Foteini F Poulis Aristarchos A Tsantes Andreas G AG Bonovas Stefanos S Kapsimali Violetta V Tsivgoulis Georgios G Tsantes Argirios E AE
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 20181001 9_suppl
Our aim is to determine the most appropriate laboratory tests, besides anti-factor Xa (anti-FXa) chromogenic assays, to estimate the degree of anticoagulation with apixaban and compare it with that of rivaroxaban in real-world patients. Twenty patients with nonvalvular atrial fibrillation treated with apixaban 5 mg twice daily and 20 patients on rivaroxaban 20 mg once daily were studied. Conventional coagulation tests, thrombin generation assay (TGA), and thromboelastometry (nonactivated TEM [NA ...[more]